---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-014640"
form_type: "8-K"
ticker: "ARDT"
cik: "0001756655"
company_name: "Ardent Health, Inc."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:44:55.442971+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ardent Health Q4 adj EBITDA down 26.6% to $134M; 2026 guidance issued

## Summary
- Q4 total revenue $1.605B (flat YoY); net income $45M vs $114M prior year.
- Q4 adjusted EBITDA $134M (down 26.6% YoY) due to annualization of prior-year benefits.
- Full-year 2025 revenue $6.32B (+6%); adjusted EBITDA $545M (+9.3%); margin +20bps to 8.6%.
- 2026 guidance: revenue $6.4B-$6.7B, adjusted EBITDA $485M-$535M, reflecting headwinds.
- Net leverage improved to 0.8x; operating cash flow $471M (+49% YoY); share buyback $3M in Q4.

## SEC filing metadata
- accession: 0001628280-26-014640
- form_type: 8-K
- ticker: ARDT
- cik: 0001756655
- company_name: Ardent Health, Inc.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1756655/000162828026014640/0001628280-26-014640-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1756655/000162828026014640/ardt-20260304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-014640
- JSON: https://secwatch.observer/filing/0001628280-26-014640.json
- Plain text: https://secwatch.observer/filing/0001628280-26-014640.txt

## Key facts
- Earnings Releases
  Ardent Health, Inc. reported the quarter ended December 31, 2025 results: revenue $1,605 million, net income $45 million, EPS $0.32 per diluted share. Guidance initiated.
  - Period: the quarter ended December 31, 2025
  - Revenue: $1,605 million
  - Net income: $45 million
  - EPS: $0.32 per diluted share
  - Guidance: initiated
  - Result: reported results
  source text: See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue 4Q25 : $1.61 billion 2025 : $6.32 billion ; 6.0% growth Y/Y Net Income Attributable to Ardent Health 4Q25 : $45 million Adjusted EBITDA (1) 4Q25 : $134 million 2025 : $545 million ; 9.3% growth Y/Y
  evidence_url: https://www.sec.gov/Archives/edgar/data/1756655/000162828026014640/0001628280-26-014640-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.